HOXA5-Induced Apoptosis in Breast Cancer Cells Is Mediated by Caspases 2 and 8

Molecular and Cellular Biology

Volumn 24, Issue 2, 2004, Pages 924-935

  Chen, Hexin ^a   Chung, Seung ^a   Sukumar, Saraswati ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLLEUCYLGLUTAMYLHISTIDYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLTYROSYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLASPARTYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLGLUTAMYLISOLEUCYLASPARTYL FLUOROMETHYL KETONE; CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 8; CASPASE 9; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN P53; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA5; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; GENE; GENE INDUCTION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HOXA5 GENE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; WESTERN BLOTTING;

APOPTOSIS; BREAST NEOPLASMS; CASPASE 2; CASPASE 8; CASPASES; CELL LINE, TUMOR; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GENES, P53; HOMEODOMAIN PROTEINS; HUMANS; MUTATION; PHOSPHOPROTEINS; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0347986652     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.2.924-935.2004     Document Type: Article

References (51)

1. Abate-Shen, C. 2002. Deregulated homeobox gene expression in cancer: cause or consequence? Nat. Rev. Cancer 2:777-785.
2. Adrain, C., and S. J. Martin. 2001. The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem. Sci. 26:390-397.
3. Aubin, J., P. Chailler, D. Menard, and L. Jeannotte. 1999. Loss of Hoxa5 gene function in mice perturbs intestinal maturation. Am. J. Physiol. 277: C965-C973.
4. Bergeron, L., G. I. Perez, G. Macdonald, L. Shi, Y. Sun, A. Jurisicova, S. Varmuza, K. E. Latham, J. A. Flaws, J. C. Salter, H. Hara, M. A. Moskowitz, E. Li, A. Greenberg, J. L. Tilly, and J. Yuan. 1998. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 12:1304-1314.
5. Bodey, B., B. Bodey, Jr., S. E. Siegel, and H. E. Kaiser. 2000. Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in breast carcinomas, Anticancer Res. 20:3281-3286.
6. Budd, S. L., L. Tenneti, T. Lishnak, and S. A. Lipton. 2000. Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc. Natl. Acad. Sci. USA 97:6161-6166.
7. Cantile, M., G. Pettinato, A. Procino, I. Feliciello, L. Cindolo, and C. Cillo. 2003. In vivo expression of the whole HOX gene network in human breast cancer. Eur. J. Cancer 39:257-264.
8. Care, A., F. Felicetti, E. Meccia, L. Bottero, M. Parenza, A. Stoppacciaro, C. Peschle, and M. P. Colombo. 2001. HOXB7: a key factor for tumor-associated angiogenic switch. Cancer Res. 61:6532-6539.
9. Care, A., A. Silvani, E. Meccia, G. Mattia, C. Peschle, and M. P. Colombo. 1998. Transduction of the SkBr3 breast carcinoma cell line with the HOXB7 gene induces bFGF expression, increases cell proliferation and reduces growth factor dependence. Oncogene 16:3285-3289.
10. Care, A., A. Silvani, E. Meccia, G. Mattia, A. Stoppacciaro, G. Parmiani, C. Peschle, and M. P. Colombo. 1996. HOXB7 constitutively activates basic fibroblast growth factor in melanomas. Mol. Cell. Biol. 16:4842-4851.
11. Chariot, A., V. Castronovo, P. Le, C. Gillet, M. E. Sobel, and J. Gielen. 1996. Cloning and expression of a new HOXC6 transcript encoding a repressing protein. Biochem. J. 319:91-97.
12. Chariot, A., and J. Gielen. 1998. The HOXC6 homeodomain-containing proteins. Int. J. Biochem. Cell Biol. 30:651-655.
13. Chariot, A., L. Moreau, G. Senterre, M. E. Sobel, and V. Castronovo. 1995. Retinoic acid induces three newly cloned HOXA1 transcripts in MCF7 breast cancer cells. Biochem. Biophys. Res. Commun. 215:713-720.
14. Cillo, C., M. Cantile, A. Faiella, and E. Boncinelli. 2001. Homeobox genes in normal and malignant cells. J. Cell Physiol. 188:161-169.
15. Cillo, C., A. Faiella, M. Cantile, and E. Boncinelli. 1999. Homeobox genes and cancer. Exp. Cell Res. 248:1-9.
16. Colussi, P. A., and S. Kumar. 1999. Targeted disruption of caspase genes in mice: what they tell us about the functions of individual caspases in apoptosis. Immunol. Cell Biol. 77:58-63.
17. Duan, H., and V. M. Dixit. 1997. RAIDD is a new 'death' adaptor molecule. Nature 385:86-89.
18. Eliyahu, D., S. Evans, N. Rosen, S. Eliyahu, J. Zwiebel, S. Paik, and M. Lippman. 1994. p53Val135 temperature sensitive mutant suppresses growth of human breast cancer cells, Breast Cancer Res. Treat. 30:167-177.
19. Friedmann, Y., C. A. Daniel, P. Strickland, and C. W. Daniel. 1994. Hox genes in normal and neoplastic mouse mammary gland. Cancer Res. 54: 5981-5985.
20. Guo, Y., S. M. Srinivasula, A. Druilhe, T. Fernandes-Alnemri, and E. S. Alnemri. 2002. Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J. Biol. Chem. 277:13430-13437.
21. Gupta, S. 2002. A decision between life and death during TNF-alpha-induced signaling. J. Clin. Immunol. 22:185-194.
22. Gupta, S. 2001. Molecular steps of tumor necrosis factor receptor-mediated apoptosis. Curr. Mol. Med. 1:317-324.
23. Harvey, N. L., A. J. Butt, and S. Kumar. 1997. Functional activation of Nedd2/ICH-1 (caspase-2) is an early process in apoptosis. J. Biol. Chem. 272:13134-13139.
24. Haviv, R., L. Lindenboim, J. Yuan, and R. Stein. 1998. Need for caspase-2 in apoptosis of growth-factor-deprived PC12 cells. J. Neurosci. Res. 52:491-497.
25. Jeannotte, L., M, Lemieux, J. Charron, F. Poirier, and E. J. Robertson. 1993. Specification of axial identity in the mouse: role of the Hoxa-5 (Hox1.3) gene. Genes Dev. 7:2085-2096.
26. Jesenberger, V., K. J. Procyk, J. Yuan, S. Reipert, and M. Baccarini. 2000. Salmonella-induced caspase-2 activation in macrophages: a novel mechanism in pathogen-mediated apoptosis. J. Exp. Med. 192:1035-1046.
27. Kumar, A., M. Commane, T. W. Flickinger, C. M. Horvath, and G. R. Stark. 1997. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 278:1630-1632.
28. Kumar, S., and D. L. Vaux. 2002. Apoptosis. A cinderella caspase takes center stage. Science 297:1290-1291.
29. Lassus, P., X. Opitz-Araya, and Y. Lazebnik. 2002. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297:1352-1354.
30. Lemaire, C., K. Andreau, V. Souvannavong, and A. Adam. 1998. Inhibition of caspase activity induces a switch from apoptosis to necrosis. FEBS Lett. 425:266-270.
31. Lewis, M. T. 2000. Homeobox genes in mammary gland development and neoplasia. Breast Cancer Res. 2:158-169.
32. Li, H., L. Bergeron, V. Cryns, M. S. Pasternack, H. Zhu, L. Shi, A. Greenberg, and J. Yuan. 1997. Activation of caspase-2 in apoptosis. J. Biol. Chem. 272:21010-21017.
33. Li, L. Y., X. Luo, and X. Wang. 2001. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412:95-99.
34. Lohmann, I., N. McGinnis, M. Bodmer, and W. McGinnis. 2002. The Drosophila Hox gene deformed sculpts head morphology via direct regulation of the apoptosis activator reaper. Cell 110:457-466.
35. MacLachlan, T. K., and W. S. El-Deiry. 2002. Apoptotic threshold is lowered by p53 transactivation of caspase-6. Proc. Natl. Acad. Sci. USA 99:9492-9497.
36. Nieves-Neira, W., and Y. Pommier. 1999. Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI Anticancer Drug Screen: multifactorial relationships with topoisomerase I, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways. Int J. Cancer 82:396-404.
37. O'Connor, P. M., J. Jackman, I. Bae, T. G. Myers, S. Fan, M. Mutoh, D. A. Scudiero, A. Monks, E. A. Sausville, J. N. Weinstein, S. Friend, A. J. Fornace, Jr., and K. W. Kohn. 1997. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res. 57:4285-4300.
38. O'Reilly, L. A., P. Ekert, N. Harvey, V. Marsden, L. Cullen, D. L. Vaux, G. Hacker, C. Magnusson, M. Pakusch, F. Cecconi, IC Kuida, A. Strasser, D. C. Huang, and S. Kumar. 2002. Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9. Cell Death Differ. 9:832-841.
39. Penninger, J. M., and G. Kroemer. 2003. Mitochondria, AIF and caspases-rivaling for cell death execution. Nat. Cell Biol. 5:97-99.
40. Post, L. C., E. H. Margulies, A. Kuo, and J. W. Innis. 2000. Severe limb defects in Hypodactyly mice result from the expression of a novel, mutant HOXA13 protein. Dev. Biol. 217:290-300.
41. Raman, V., S. A. Martensen, D. Reisman, E. Evron, W. F. Odenwald, E. Jaffee, J. Marks, and S. Sukumar. 2000. Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405:974-978.
42. Scheller, C., S. Sopper, C. Ehrhardt, E. Flory, P. Chen, E. Koutsilieri, S. Ludwig, V. ter Meulen, and C. Jassoy. 2002. Caspase inhibitors induce a switch from apoptotic to proinflammatory signaling in CD95-stimulated T lymphocytes. Eur. J. Immunol. 32:2471-2480.
43. Slee, E. A., C. Adrain, and S. J. Martin. 1999. Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ. 6:1067-1074.
44. Stadler, H. S., K. M. Higgins, and M. R. Capecchi. 2001. Loss of Eph-receptor expression correlates with loss of cell adhesion and chondrogenic capacity in Hoxa13 mutant limbs. Development 128:4177-4188.
45. Susin, S. A., H. K. Lorenzo, N. Zamzami, I. Marzo, C. Brenner, N. Larochette, M. C. Prevost, P. M. Alzari, and G. Kroemer. 1999. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J. Exp. Med. 189:381-394.
46. Takai, Y., J. Canning, G. I. Perez, J. K. Pru, J. J. Schlezinger, D. H. Sherr, R. N. Kolesnick, J. Yuan, R. A. Flavell, S. J. Korsmeyer, and J. L. Tilly. 2003. Bax, caspase-2, and caspase-3 are required for ovarian follicle loss caused by 4-vinylcyclohexene diepoxide exposure of female mice in vivo. Endocrinology 144:69-74.
47. Van de Craen, M., W. Declercq, I. Van den brande, W. Fiers, and P. Vandenabeele. 1999. The proteolytic procaspase activation network: an in vitro analysis. Cell Death Differ. 6:1117-1124.
48. Wang, L., M. Miura, L. Bergeron, H. Zhu, and J. Yuan. 1994. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78:739-750.
49. Yu, J., L. Zhang, P. M. Hwang, C. Rago, K. W. Kinzler, and B. Vogelstein. 1999. Identification and classification of p53-regulated genes. Proc. Natl. Acad. Sci. USA 96:14517-14522.
50. Yu, S. W., H. Wang, M. F. Poitras, C. Coombs, W. J. Bowers, H. J. Federoff, G. G. Poirier, T. M. Dawson, and V. L. Dawson. 2002. Mediation of poly-(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297:259-263.
51. Zhang, X., T. Zhu, Y. Chen, H. C. Mertani, K. O. Lee, and P. E. Lobie. 2003. Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene. J. Biol. Chem. 278:7580-7590.